doi:10.3969/j.issn.1673-8640.2023.09.016

Abstract

CLC Number:

R378.91

Figures/Tables 5

References 22

[1]	World Health Organization. Global tuberculosis report 2020[EB/OL].(2020-10-15)[2022-02-14]. https://www.who.int/publications/i/item/9789240013131.
[2]	刘君, 裴豪, 陈燕燕, 等. 磁珠法检测抗酸杆菌的方法建立与临床应用[J]. 中华医院感染学杂志, 2011, 21(22):4861-4863.
[3]	HUANG W, QI Y, DIAO Y, et al. Use of resuscitation-promoting factor proteins improves the sensitivity of culture-based tuberculosis testing in special samples[J]. Am J Respir Crit Care Med, 2014, 189(5):612-614. DOI URL
[4]	李晓倩, 王智慧, 池跃朋, 等. 血清MMP-9测定、肺泡灌洗液Xpert MTB/RIF检测、INF-γ释放试验单独和联合检测对肺结核的诊断效能[J]. 检验医学, 2022, 37(1):11-15.
[5]	刘军, 刘涛, 戴碗琴, 等. Xpert MTB/RIF技术在结核分枝杆菌利福平耐药性快速检测中的价值[J]. 检验医学, 2020, 35(9):920-923.
[6]	申洁, 贾莉, 董小帅, 等. 不同检测方法快速诊断结核性胸膜炎临床评价[J]. 检验医学, 2019, 34(3):221-224.
[7]	刘君, 裴豪, 王俊, 等. CBA技术与两种常用快速检测技术在结核病诊断运用中的比较[J]. 中华医院感染学杂志, 2016, 26(24):5569-5571.
[8]	PAI M, RILEY L W, COLFORD J M. Interferon-γ assays in the immunodiagnosis of tuberculosis:a systematic review[J]. Lancet Infect Dis, 2004, 4(12):761-776. DOI URL
[9]	PAI M, DENKINGER C M, KIK S V, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection[J]. Clin Microbiol Rev, 2014, 27(1):3-20. DOI URL
[10]	AGOSTINIS A, HEFFERNAN C, LONG R, et al. Interferon-gamma release assays for latent tuberculosis infection screening in Canadian federal correctional facilities[J]. Int J Tuberc Lung Dis, 2021, 25(6):447-452. DOI PMID
[11]	RAHMAN S, IRFAN M, SIDDIQUI M A R. Role of interferon gamma release assay in the diagnosis and management of Mycobacterium tuberculosis-associated uveitis:a review[J]. BMJ Open Ophthalmol, 2021, 6(1):e000663. DOI URL
[12]	HANRAHAN C F, THERON G, BASSETT J, et al. Xpert MTB/RIF as a measure of sputum bacillary burden.Variation by HIV status and immunosuppression[J]. Am J Respir Crit Care Med, 2014, 189(11):1426-1434. DOI URL
[13]	THERON G, PETER J, VAN ZYL-SMIT R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting[J]. Am J Respir Crit Care Med, 2011, 184(1):132-140. DOI URL
[14]	GARTON N J, WADDELL S J, SHERRATT A L, et al. Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum[J]. PLoS Med, 2008, 5(4):e75. DOI URL
[15]	ESAULOVA E, DAS S, SINGH D K, et al. The immune landscape in tuberculosis reveals populations linked to disease and latency[J]. Cell Host Microbe, 2021, 29(2):165-178. DOI PMID
[16]	DANIEL J, DEB C, DUBEY V S, et al. Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture[J]. J Bacteriol, 2004, 186(15):5017-5030. DOI URL
[17]	VAN LOON W, GOMEZ M P, JOBE D, et al. Use of resuscitation promoting factors to screen for tuberculosis infection in household-exposed children in the Gambia[J]. BMC Infect Dis, 2020, 20(1):469. DOI PMID
[18]	VERMA A, RADOTRA B D, SHAEMA S. Role of resuscitation promoting factors in reactivation of latent tuberculosis during high glucose conditions employing human granuloma in vitro model[J]. Microb Pathog, 2021, 158:105068. DOI URL
[19]	VERMA A, KAUR M, SINGH L V, et al. Reactivation of latent tuberculosis through modulation of resuscitation promoting factors by diabetes[J]. Sci Rep, 2021, 11(1):19700. DOI PMID
[20]	ROSSER A, STOVER C, PAREEK M, et al. Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection[J]. Crit Rev Microbiol, 2017, 43(5):621-630. DOI URL
[21]	MUKAMOLOVA G V, TURAPOV O, MALKIN J, et al. Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in sputum[J]. Am J Respir Crit Care Med, 2010, 181(2):174-180. DOI URL
[22]	OPOTA O, MAZZA-STALDER J, GREUB G, et al. The rapid molecular test Xpert MTB/RIF ultra:towards improved tuberculosis diagnosis and rifampicin resistance detection[J]. Clin Microbiol Infect, 2019, 25(11):1370-1376. DOI URL

方法	例数	阳性例数	阴性例数	阳性检出率/%
双相培养	175	101	74	57.7
浓缩集菌抗酸染色镜检	175	73	102	41.7^*
T-SPOT	115	82	33	71.3^*
Xpert MTB/RIF	151	81	70	53.6

方法	例数	阳性例数	阴性例数	阳性检出率/%
双相培养	175	101	74	57.7
浓缩集菌抗酸染色镜检	175	73	102	41.7^*
T-SPOT	115	82	33	71.3^*
Xpert MTB/RIF	151	81	70	53.6

检测方法	阳性例数	阴性例数	阳性检出率/%
双相培养	21	40	35.0
T-SPOT	40	21	65.6^*
Xpert MTB/RIF	20	41	32.7

检测方法	阳性例数	阴性例数	阳性检出率/%
双相培养	21	40	35.0
T-SPOT	40	21	65.6^*
Xpert MTB/RIF	20	41	32.7

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 22

Related Articles 15

Recommended Articles

Metrics

[1]	RU Haohao, CHEN Lianyong, YANG Xing, CHEN Tao, YAN Shuangqun, XU Lin. Analysis of rifampicin resistance in Mycobacterium tuberculosis determined by Xpert MTB/RIF and phenotypic drug susceptibility test [J]. Laboratory Medicine, 2023, 38(11): 1032-1035.
[2]	SUN Xinlin, YE Xingming, LI Qian, ZHAO Lijun. Bronchoscopy combined with sputum Mycobacterium tuberculosis ribonucleic acid and serum Mycobacterium tuberculosis specific antibody determinations for diagnosis of negative pulmonary tuberculosis [J]. Laboratory Medicine, 2023, 38(9): 870-873.
[3]	MIAO Xingguo, YE Hui, SU Feifei. Relationship between GeneXpert MTB/RIF assay determination load and Mycobacterium tuberculosis culture and phenotype of rifampicin resistance [J]. Laboratory Medicine, 2023, 38(9): 874-877.
[4]	. [J]. Laboratory Medicine, 2023, 38(5): 494-496.
[5]	. [J]. Laboratory Medicine, 2021, 36(9): 988-990.
[6]	YU Chenlei, JIANG Yuan, LI Jing, WANG Lili, CHEN Wei, SHEN Xuhui, ZHANG Yangyi. Application of BAC spreader for minimum inhibitory concentration determination in Mycobacterium tuberculosis [J]. Laboratory Medicine, 2021, 36(6): 650-655.
[7]	. [J]. Laboratory Medicine, 2020, 35(9): 960-963.
[8]	LIU Jun, LIU Tao, DAI Wanqin, WANG Yixiang, HOU Yanqiang. Role of Xpert MTB/RIF system in the rapid detection of Mycobacterium tuberculosis and rifampicin resistance [J]. Laboratory Medicine, 2020, 35(9): 920-923.
[9]	PENG Rong, FEI Fengying.. Research on genotype and relationship of genotype with drug-resistant phenotypes from 266 Mycobacterium tuberculosis in Qingpu District [J]. Laboratory Medicine, 2015, 30(10): 983-986.
[10]	XU Yuanhong;YUE Ji;QIN Lianhua;LUO Mei;HE Jianlan;LI Qingfeng;HU Zhangyi. Clinical evaluation of determination of enzyme-linked oligonucleotide sorbent assay for serum IgG antibodies in patients with tuberculosis [J]. , 2011, 26(12): 840-844.
[11]	LIU Longping;LUO Kewen;ZHANG Tingmei;WANG Yan;CHEN Hongmei;TANG Faqin. Analysis on clinical drug resistance of multi-drug resistant Mycobacterium tuberculosis [J]. , 2010, 25(09): 683-685.
[12]	. [J]. , 2010, 25(03): 252-253.
[13]	. [J]. , 2009, 24(12): 860-865.
[14]	. [J]. , 2007, 22(06): 647-647.
[15]	DAI Junhua;KANG Xiangdong;WU Rong;WU Yiyun. Analysis of primary drug resistance of Mycobacterium tuberculosis in Shanghai Putuo district from 1996 to 2003 year [J]. , 2005, 20(05): 467-469.